Yildiz, J. Et Al. 2021. High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors. Journal of B.U.ON. , vol.26, no.6 , 2531-2536.

Yildiz, J., Ulu, B. U., Yigenoglu, T. N., Basci, S., Bakirtas, M., Sahin, D., ... Darcin, T.(2021). High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors. Journal of B.U.ON. , vol.26, no.6, 2531-2536.

Yildiz, Jale Et Al. "High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors," Journal of B.U.ON. , vol.26, no.6, 2531-2536, 2021

Yildiz, Jale Et Al. "High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors." Journal of B.U.ON. , vol.26, no.6, pp.2531-2536, 2021

Yildiz, J. Et Al. (2021) . "High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors." Journal of B.U.ON. , vol.26, no.6, pp.2531-2536.

@article{article, author={Jale Yildiz Et Al. }, title={High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors}, journal={Journal of B.U.ON.}, year=2021, pages={2531-2536} }